DAIC

DECEMBER 12, 2023

Even so, research has been conflicting on whether patients would benefit from more aggressive early postoperative anticoagulation treatment. Mayo Clinic researchers analyzed nationwide data on more than 10,000 patients who underwent bioprosthetic aortic valve replacement. "The

Aortic valve 116

Aortic valve Aortic Blood Clot Medicare 116

DAIC

JANUARY 30, 2025

29, 2025 Researchers atOchsner Health, led byHernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence. tim.hodson Thu, 01/30/2025 - 15:31 Jan.

Stroke 52

Stroke Strokes Outcomes Quality of Life 52

DAIC

JANUARY 24, 2025

Medicare beneficiaries who underwent CABG from 2001 to 2019. The researchers found that patients who received multi-arterial grafting (MAG) had improved survival over those who received single-arterial grafting (SAG), supporting findings from prior retrospective studies. tim.hodson Fri, 01/24/2025 - 11:51 Jan.

Outcomes 52

Outcomes Coronary Artery Bypass Graft Cardiothoracic Medicare 52

Stroke Journal

DECEMBER 8, 2023

BACKGROUND:Stroke is the fifth leading cause of death in the United States, one of the leading contributors to Medicare cost, including through Medicare hospice benefits, and the rate of stroke mortality has been increasing since 2013. from 78 812 to 160 884. from 78 812 to 160 884. P<0.001). P<0.001).

Medicare 40

Medicare Stroke Strokes Dementia 40

DAIC

MARCH 10, 2025

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

Hypertension Journal

JANUARY 16, 2024

Hypertension, Volume 81, Issue 2 , Page e7-e9, February 1, 2024.

Medicaid 45

Medicaid Blood Pressure Medicare Research 45

DAIC

MARCH 13, 2024

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by CMS for both treatment and control procedures.

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

JUNE 4, 2024

In January 2024, the Centers for Medicare and Medicaid Services (CMS) began requiring health care organizations to screen for five social factors: Food insecurity Interpersonal safety Housing insecurity Transportation Utilities The purpose of these screenings is to encourage engagement of community-based organizations with resources to address SDOH.

Stroke 115

Stroke Strokes Innovation Research 115

DAIC

APRIL 24, 2024

CVD is especially prevalent in the Medicare-aged population, affecting more than 75 percent of those aged 60-79 and more than 90 percent of those aged 80 and over. Yet, CVD remains the leading cause of death in the U.S.,

Blood Pressure 116

Blood Pressure Cholesterol Technology Heart attacks 116

Stroke Journal

NOVEMBER 22, 2024

While hypoglycemia has been established as a risk factor for cardiovascular events such as acute ischemic stroke (AIS), there is limited research demonstrating hypoglycemic events as stroke triggers. More research is needed to assess the link between the severity of hypoglycemia and stroke occurrence, as well as the severity of the stroke.

Diabetes 71

Diabetes Stroke Strokes Medicare 71

Journal of the American Heart Association

MARCH 26, 2025

Methods and ResultsIn this retrospective study using complete, deidentified inpatient Medicare data (20162019), we identified incident acute ischemic stroke admissions, demographics, and hospitallevel variables.

Stroke 45

Stroke Strokes Medicare Certification 45

Journal of the American Heart Association

JANUARY 10, 2025

Each patient was matched with their claims from Medicare Provider Analysis and Review to compare CPT withInternational Classification of Diseases,Tenth Revision,Procedure Coding System(ICD10PCS) claims submitted by health care facilities to bill for PVIs.

Atrial Fibrillation 45

Atrial Fibrillation Pulmonary Medicare Inpatient 45

Stroke Journal

FEBRUARY 1, 2024

As of 2023, Center for Medicare & Medicaid Services uses NIHSS as a risk adjustment variable. Medicare and Mount Sinai Health System registry data were linked using a matching algorithm. of Medicare cases even though it was documented in 93.1% Index AIS admissions were identified using the ICD-10-CM code of I63.x.

Medicare 40

Medicare Document Stroke Strokes 40

DAIC

DECEMBER 8, 2023

The company recently announced it has received CMS approval for Medicare coverage during the DRAIN-HF pivotal trial. We look forward to working with our investigators and research teams to advance the scientific evidence around this groundbreaking technology." Fain, MD , President and Chief Executive Officer, Procyrion. "We

Technology 113

Technology Heart Failure Heart Transplant Transplant 113

DAIC

JANUARY 12, 2024

head of University College London’s Centre for Amyloidosis and research lead at the UK National Amyloidosis Centre. Medicare population. Given the efficacy and safety of acoramidis demonstrated in this trial, I am hopeful that it will soon be available to the benefit of the growing global population of patients diagnosed with ATTR-CM.”

Cardiomyopathy 105

Cardiomyopathy Medicare Cancer Hospital 105

DAIC

MARCH 7, 2024

The data was presented today by Amish Raval , MD, Director of Clinical Cardiovascular Research and Professor of Medicine at the University of Wisconsin-Madison at the Technology and Heart Failure Therapeutics (THT) 2024 annual meeting. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement.

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

DAIC

MAY 2, 2024

The clinical research results presented for the roll-in cohort from our CardiAMP CMI Trial highlight BioCardia’s continuing efforts to transform the treatment paradigm in refractory angina through the promise of a one-time cost effective minimally invasive autologous cell-based therapy,” said Peter Altman , President and CEO.

Ischemia 95

Ischemia Angina Heart Failure Outcomes 95

Cardiovascular Diabetology

JULY 7, 2024

The costs were direct total health care expenditures (out-of-pocket payments and payments by private insurance, Medicaid, Medicare, and other sources) from various sources (office-based visits, hospital outpatient, emergency room, inpatient hospital, pharmacy, home health care, and other medical expenditures).

Diabetes 72

Diabetes Cardiovascular Disease Drug Costs Medicaid 72

DAIC

MARCH 31, 2025

Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. 2 The Zio monitor is a prescription-only, single-use ECG monitor that continuously records data for up to 14 days. Circulation: Heart Failure. 2013;6(3):606-619. doi:[link] 10 Reynolds et al. Am Heart J. 2024;269:2534.

Arrhythmia 52

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure 52

DAIC

JULY 25, 2024

The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by Center for Medicare and Medicaid Services (CMS) for both treatment and control procedures. CAUTION - Limited by United States law to investigational use.

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

DAIC

JUNE 12, 2024

According to prior published research, IVUS supports accurate diagnosis of venous disease and has been shown to change 57% of treatment plans compared to venography alone [4]. Utilization of and Outcomes Associated with Intravascular Ultrasound during Deep Venous Stent Placement among Medicare Beneficiaries. 2017;5:678-687. [5]

Stents 105

Stents Stent Anatomy Ultrasound 105

Stroke Journal

DECEMBER 14, 2023

Implantable vagus nerve stimulation, paired with high-dose occupational therapy, has been shown to be effective in improving upper limb function among patients with stroke and received regulatory approval from the US Food and Drug Administration and the Centers for Medicare & Medicaid Services.

Stroke 40

Stroke Strokes Best Practices Medicaid 40

DAIC

MARCH 10, 2025

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

DAIC

MARCH 7, 2024

Coronary Computed Tomography Angiography Developments At RSNA23, ITN had the opportunity to speak with Bhvita Jani, principal analyst at Signify Research, about advancements and trends in medical imaging, including the development of coronary CTA. Halpern, MD, and Vijay M. Rao, MD, FACR, from Thomas Jefferson University Hospitals.

Technology 111

Technology Document Cardiovascular Imaging Cancer 111

Circulation

NOVEMBER 11, 2024

We applied a claims-based algorithm used by researchers and policymakers to identify if testing was low-value or appropriate. Using Current Procedural Technology codes, the first 150 patients that underwent carotid ultrasound in 2021 were identified.

Ultrasound 40

Ultrasound Medicare Technology Circulation 40

Stroke Journal

JANUARY 30, 2025

Medicare) patients (1.82, 1.45 2.26) had higher odds of receiving surgical AVM treatment (Table 1). Further research is warranted to address these inequities and improve outcomes. NHW patients (0.80, 0.64 0.99) and females (0.75, 0.64 -0.87) had lower odds of receiving surgical AVM treatment, whereas Asian (vs.

Hemorrhage 40

Hemorrhage Medicare Inpatient Research 40

Society of Thoracic Surgeons - Congenital

JANUARY 7, 2025

A study presented this week at The Society of Thoracic Surgeons 61st Annual Meeting explores findings in more than a million US Medicare beneficiaries who underwent CABG from 2001 to 2019. They noted that because their analysis was focused on the Medicare population, the cohort was limited to older patients.

Outcomes 40

Outcomes Cardiothoracic Coronary Artery Bypass Graft Medicare 40

Stroke Journal

JANUARY 30, 2025

We defined an ED-hospital dyad to be vertically integrated if the ED and hospital shared the same health system ID in the Agency for Healthcare Research and Quality's Compendium of US Health Systems. The effect that vertical integration has on emergency stroke care is unclear.

Hospital 40

Hospital Stroke Strokes Medicare 40

Society of Thoracic Surgeons - Technology

OCTOBER 21, 2021

The linkage also would allow registries to continue providing critical information for approval and coverage of innovative medical interventions and preserve the government’s authority to authorize Medicare Coverage with Evidence Development (CED). The ACC looks forward to working with Reps. Learn more at sts.org. For more, visit acc.org.

Technology 40

Technology Coronary Artery Bypass Graft Cardiothoracic Aortic valve 40

Cardiomatics

FEBRUARY 9, 2022

Therefore, in cooperation with the Medical University of Warsaw, we applied for a grant from The National Center for Research and Development. Cardiovascular Development and Disease Do you conduct research in which you use ECG recordings? Is there a way to optimize the work of a clinician? We believe so. Try our solution. Heart Fail.

Heart Failure 52

Heart Failure Myocardial Infarction Medicare Defibrillator 52

Wellnest

JUNE 19, 2023

The development has urged us to integrate the latest Artificial Intelligence with the healthcare system, including Cardiac Medicare. It has been increasing at an alarming rate of 28.1% since the past two decades as one of the leading causes of mortality. What is Artificial Intelligence?

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Cardiometabolic Health Congress

JANUARY 19, 2024

These pharmaceutical giants—who control over 90% of the insulin market —have long cited the need to charge high prices for their medications to offset research and development costs. The recent price cuts mirror the insulin caps for Medicare enrollees that took effect last year as part of President Biden’s Inflation Reduction Act.

Diabetes 59

Diabetes Medicare Diet CME 59

The Beat Blog

MARCH 30, 2022

In 2018, cardiovascular outcomes researcher Dr. Leslee Shaw and her collaborators published “10-Year Resource Utilization and Costs for Cardiovascular Care.” Cardiovascular diseases (CVD) affect nearly half of all American adults, and in addition to their impact on health outcomes, they have significant economic implications.

Blood Pressure 52

Blood Pressure Diabetes Risk Factors Hypertension 52

Dr. S. Venkatesan MD

JANUARY 1, 2025

What happened to top 10 cardiology research papers of 2023 ? In that sense, every year, we see more than 100s of RCT get released various research centers with varying credibility. most) of us lack the expertise of picking the genuine , winning research especially in the arena of new drugs and devices. Did we follow up ?

Cardiogenic Shock 59

Cardiogenic Shock Plaque Academic Bicuspid/Mitral 59